To Abreviate or not to Abreviate [Regulatives / Guidelines]

posted by KR – India, 2010-04-26 08:03 (5894 d 20:46 ago) – Posting: # 5223
Views: 18,494

Dear EM,

Thanks for the reply. The main problem is how does the Emax model given in the OGD guidance give the output as the same dose (i.e. 60 mg tid or 2 x 60 mg tid) for both test and reference will be given to all the volunteers and hence, how to establish dose response relationship ?

Thanks...

KR


Edit: Full quote removed. Please delete anything from the text of the original poster which is not necessary in understanding your answer; see also this post. [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,571 registered users;
135 visitors (0 registered, 135 guests [including 20 identified bots]).
Forum time: 04:49 CEST (Europe/Vienna)

Always listen to experts.
They’ll tell you what can’t be done and why.
Then do it.    Robert A. Heinlein

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5